Dynavax Technologies Corp (NASDAQ:DVAX)

CAPS Rating: 3 out of 5

A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory.

Results 21 - 28 of 28 : « Previous 1 2

Recs

1
Member Avatar halmcneely (35.04) Submitted: 11/24/2006 5:17:17 PM : Outperform Start Price: $7.70 DVAX Score: -52.74

Stong findings for a much-needed vaccine; results exceed early prognosis. Large populations with Rag Weed Allergy get sustained releif.

Recs

0
Member Avatar moscabo (20.04) Submitted: 11/17/2006 11:06:39 AM : Outperform Start Price: $7.60 DVAX Score: -52.60

Bear Stearns upgraded to outperform 11/17

Recs

0
Member Avatar baronvonlong (< 20) Submitted: 10/23/2006 6:02:49 PM : Outperform Start Price: $6.20 DVAX Score: -43.43

alot of good things in their pipeline

Recs

0
Member Avatar bpub (38.91) Submitted: 10/16/2006 4:28:32 PM : Outperform Start Price: $7.10 DVAX Score: -51.57

Heavy insider trading.

Recs

0
Member Avatar bikdout (< 20) Submitted: 10/12/2006 1:45:38 PM : Outperform Start Price: $6.62 DVAX Score: -47.94

This small cap stock has just broken out with experimantal studies showing their new product does effectively relieve ragweed allergies.

Recs

0
Member Avatar Inv4Peter (< 20) Submitted: 10/11/2006 12:12:18 PM : Outperform Start Price: $6.86 DVAX Score: -51.05

New product hype will die down in a few weeks.

Recs

0
Member Avatar b5l8 (73.64) Submitted: 10/6/2006 5:37:50 PM : Outperform Start Price: $7.29 DVAX Score: -54.04

MY on3 D4y PrED1c+10n on +Hi5 5+OcK 1$ +7%;-)

Recs

0
Member Avatar napainvestor (< 20) Submitted: 10/5/2006 1:34:46 PM : Outperform Start Price: $6.18 DVAX Score: -45.01

I think that this company is a great 'take-over' candidate.

Results 21 - 28 of 28 : « Previous 1 2

Featured Broker Partners


Advertisement